Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mesa Labs Inc (NQ: MLAB )

109.09 +8.23 (+8.16%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Mesa Labs Inc

< Previous 1 2 Next >
MLAB Stock Earnings: Mesa Laboratories Beats EPS, Beats Revenue for Q4 2024
MLAB stock results show that Mesa Laboratories beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Earnings Preview: Mesa Laboratories
Via Benzinga
Evercore ISI Group Upgrades Mesa Laboratories: Here's What You Need To Know
Via Benzinga
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
Recap: Mesa Laboratories Q4 Earnings
Via Benzinga
Mesa Laboratories's Earnings Outlook
Via Benzinga
Mesa Laboratories's Return on Invested Capital Insights
Via Benzinga
Earnings Scheduled For February 5, 2024
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is estimated to report quarterly earnings at $0.26 per share on revenue of $43.92 million. 
Via Benzinga
Cogent Communications, Trimble And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by over 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Earnings Outlook For Mesa Laboratories
Via Benzinga
Mesa Laboratories's Return On Capital Employed Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Earnings Scheduled For February 6, 2023
Companies Reporting Before The Bell • Cummins (NYSE:CMI) is projected to report quarterly earnings at $4.56 per share on revenue of $7.21 billion. 
Via Benzinga
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on... 
Via Benzinga
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Mesa Laboratories (MLAB) Stock Is Getting Hammered Today
Mesa Laboratories Inc (NASDAQ: MLAB) shares are trading lower by 12.89% to $160.40 Tuesday morning after the company announced its Clinical Genomics Division customer, Sema4, will exit the reproductive... 
Via Benzinga
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry. 
Via Benzinga
Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60. 
Via Benzinga
Mesa Laboratories: Q2 Earnings Insights
Mesa Laboratories (NASDAQ:MLAB) reported its Q2 earnings results on Thursday, November 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Mesa Laboratories posted... 
Via Benzinga
Mesa Laboratories's Return on Invested Capital Insights
According to Benzinga Pro data, during Q1, Mesa Laboratories (NASDAQ:MLAB) posted sales of $50.45 million. Earnings were up 19.39%, but Mesa Laboratories still reported an overall loss of $1.44... 
Via Benzinga
Mesa Laboratories: Q1 Earnings Insights
  Mesa Laboratories (NASDAQ:MLAB) reported its Q1 earnings results on Thursday, August 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Mesa Laboratories: Q4 Earnings Insights
Mesa Laboratories (NASDAQ:MLAB) reported its Q4 earnings results on Tuesday, May 31, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Mesa Laboratories: Q3 Earnings Insights
  Mesa Laboratories (NASDAQ:MLAB) reported its Q3 earnings results on Thursday, February 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
How Good Are Mesa Laboratories's Earnings? | Return On Invested Capital
According to Benzinga Pro, during Q2, Mesa Laboratories (NASDAQ:MLAB) earned $4.20 million, a 34.52% increase from the preceding quarter. Mesa Laboratories also posted a total of... 
Via Benzinga
Mesa Labs Scoops Up Molecular Diagnostics Tools Firm For $300M
Mesa Laboratories Inc (NASDAQ: MLAB) has agreed to acquire Agena Bioscience Inc for a cash purchase price of $300 million. The San Diego, California-based... 
Via Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... 
Via Benzinga
Exposures COVID-19
Looking Into Mesa Laboratories's Return On Capital Employed
According to Benzinga Pro, during Q1, Mesa Laboratories (NASDAQ:MLAB) earned $3.12 million, a 27.3% increase from the preceding quarter. Mesa Laboratories's sales decreased to $34... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.